A Study of Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma

Clinical trial NCT01164007 · COMPLETED

Trial details

NCT number: NCT01164007
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Melanoma

Start date: 2006-06-30
Primary completion: 2012-05-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.